These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
536 related articles for article (PubMed ID: 33140861)
1. Blood molecular markers associated with COVID-19 immunopathology and multi-organ damage. Chen YM; Zheng Y; Yu Y; Wang Y; Huang Q; Qian F; Sun L; Song ZG; Chen Z; Feng J; An Y; Yang J; Su Z; Sun S; Dai F; Chen Q; Lu Q; Li P; Ling Y; Yang Z; Tang H; Shi L; Jin L; Holmes EC; Ding C; Zhu TY; Zhang YZ EMBO J; 2020 Dec; 39(24):e105896. PubMed ID: 33140861 [TBL] [Abstract][Full Text] [Related]
2. NMR Spectroscopic Windows on the Systemic Effects of SARS-CoV-2 Infection on Plasma Lipoproteins and Metabolites in Relation to Circulating Cytokines. Lodge S; Nitschke P; Kimhofer T; Coudert JD; Begum S; Bong SH; Richards T; Edgar D; Raby E; Spraul M; Schaefer H; Lindon JC; Loo RL; Holmes E; Nicholson JK J Proteome Res; 2021 Feb; 20(2):1382-1396. PubMed ID: 33426894 [TBL] [Abstract][Full Text] [Related]
3. Longitudinal antibody repertoire in "mild" versus "severe" COVID-19 patients reveals immune markers associated with disease severity and resolution. Ravichandran S; Lee Y; Grubbs G; Coyle EM; Klenow L; Akasaka O; Koga M; Adachi E; Saito M; Nakachi I; Ogura T; Baba R; Ito M; Kiso M; Yasuhara A; Yamada S; Sakai-Tagawa Y; Iwatsuki-Horimoto K; Imai M; Yamayoshi S; Yotsuyanagi H; Kawaoka Y; Khurana S Sci Adv; 2021 Mar; 7(10):. PubMed ID: 33674317 [TBL] [Abstract][Full Text] [Related]
4. Early immune markers of clinical, virological, and immunological outcomes in patients with COVID-19: a multi-omics study. Hu Z; van der Ploeg K; Chakraborty S; Arunachalam PS; Mori DAM; Jacobson KB; Bonilla H; Parsonnet J; Andrews JR; Holubar M; Subramanian A; Khosla C; Maldonado Y; Hedlin H; de la Parte L; Press K; Ty M; Tan GS; Blish C; Takahashi S; Rodriguez-Barraquer I; Greenhouse B; Butte AJ; Singh U; Pulendran B; Wang TT; Jagannathan P Elife; 2022 Oct; 11():. PubMed ID: 36239699 [TBL] [Abstract][Full Text] [Related]
5. Viral RNA load in plasma is associated with critical illness and a dysregulated host response in COVID-19. Bermejo-Martin JF; González-Rivera M; Almansa R; Micheloud D; Tedim AP; Domínguez-Gil M; Resino S; Martín-Fernández M; Ryan Murua P; Pérez-García F; Tamayo L; Lopez-Izquierdo R; Bustamante E; Aldecoa C; Gómez JM; Rico-Feijoo J; Orduña A; Méndez R; Fernández Natal I; Megías G; González-Estecha M; Carriedo D; Doncel C; Jorge N; Ortega A; de la Fuente A; Del Campo F; Fernández-Ratero JA; Trapiello W; González-Jiménez P; Ruiz G; Kelvin AA; Ostadgavahi AT; Oneizat R; Ruiz LM; Miguéns I; Gargallo E; Muñoz I; Pelegrin S; Martín S; García Olivares P; Cedeño JA; Ruiz Albi T; Puertas C; Berezo JÁ; Renedo G; Herrán R; Bustamante-Munguira J; Enríquez P; Cicuendez R; Blanco J; Abadia J; Gómez Barquero J; Mamolar N; Blanca-López N; Valdivia LJ; Fernández Caso B; Mantecón MÁ; Motos A; Fernandez-Barat L; Ferrer R; Barbé F; Torres A; Menéndez R; Eiros JM; Kelvin DJ Crit Care; 2020 Dec; 24(1):691. PubMed ID: 33317616 [TBL] [Abstract][Full Text] [Related]
6. Complement Anaphylatoxins and Inflammatory Cytokines as Prognostic Markers for COVID-19 Severity and In-Hospital Mortality. Alosaimi B; Mubarak A; Hamed ME; Almutairi AZ; Alrashed AA; AlJuryyan A; Enani M; Alenzi FQ; Alturaiki W Front Immunol; 2021; 12():668725. PubMed ID: 34276659 [TBL] [Abstract][Full Text] [Related]
7. Metabolomics study of COVID-19 patients in four different clinical stages. Valdés A; Moreno LO; Rello SR; Orduña A; Bernardo D; Cifuentes A Sci Rep; 2022 Jan; 12(1):1650. PubMed ID: 35102215 [TBL] [Abstract][Full Text] [Related]
8. Early prediction of COVID-19 severity using extracellular vesicle COPB2. Fujita Y; Hoshina T; Matsuzaki J; Yoshioka Y; Kadota T; Hosaka Y; Fujimoto S; Kawamoto H; Watanabe N; Sawaki K; Sakamoto Y; Miyajima M; Lee K; Nakaharai K; Horino T; Nakagawa R; Araya J; Miyato M; Yoshida M; Kuwano K; Ochiya T J Extracell Vesicles; 2021 Jun; 10(8):e12092. PubMed ID: 34122778 [TBL] [Abstract][Full Text] [Related]
9. SARS-CoV-2 viremia is associated with distinct proteomic pathways and predicts COVID-19 outcomes. Li Y; Schneider AM; Mehta A; Sade-Feldman M; Kays KR; Gentili M; Charland NC; Gonye AL; Gushterova I; Khanna HK; LaSalle TJ; Lavin-Parsons KM; Lilley BM; Lodenstein CL; Manakongtreecheep K; Margolin JD; McKaig BN; Parry BA; Rojas-Lopez M; Russo BC; Sharma N; Tantivit J; Thomas MF; Regan J; Flynn JP; Villani AC; Hacohen N; Goldberg MB; Filbin MR; Li JZ J Clin Invest; 2021 Jul; 131(13):. PubMed ID: 34196300 [TBL] [Abstract][Full Text] [Related]
10. Metabolic predictors of COVID-19 mortality and severity: a survival analysis. Abdallah AM; Doudin A; Sulaiman TO; Jamil O; Arif R; Sada FA; Yassine HM; Elrayess MA; Elzouki AN; Emara MM; Thillaiappan NB; Cyprian FS Front Immunol; 2024; 15():1353903. PubMed ID: 38799469 [TBL] [Abstract][Full Text] [Related]
11. Early postmortem mapping of SARS-CoV-2 RNA in patients with COVID-19 and the correlation with tissue damage. Deinhardt-Emmer S; Wittschieber D; Sanft J; Kleemann S; Elschner S; Haupt KF; Vau V; Häring C; Rödel J; Henke A; Ehrhardt C; Bauer M; Philipp M; Gaßler N; Nietzsche S; Löffler B; Mall G Elife; 2021 Mar; 10():. PubMed ID: 33781385 [TBL] [Abstract][Full Text] [Related]
12. Multiomics: unraveling the panoramic landscapes of SARS-CoV-2 infection. Wang X; Xu G; Liu X; Liu Y; Zhang S; Zhang Z Cell Mol Immunol; 2021 Oct; 18(10):2313-2324. PubMed ID: 34471261 [TBL] [Abstract][Full Text] [Related]
13. Biomarkers and Immune Repertoire Metrics Identified by Peripheral Blood Transcriptomic Sequencing Reveal the Pathogenesis of COVID-19. Liu Y; Wu Y; Liu B; Zhang Y; San D; Chen Y; Zhou Y; Yu L; Zeng H; Zhou Y; Zhou F; Yang H; Yin L; Huang Y Front Immunol; 2021; 12():677025. PubMed ID: 34504487 [TBL] [Abstract][Full Text] [Related]